Propylene Glycol Pharmacokinetics and Effects after Intravenous Infusion in Humans

@article{Speth1987PropyleneGP,
  title={Propylene Glycol Pharmacokinetics and Effects after Intravenous Infusion in Humans},
  author={Paul A. J. Speth and Tom B. Vree and N F Neilen and P H M de Mulder and David Richard Newell and Martin Eric Gore and Ben E. de Pauw},
  journal={Therapeutic Drug Monitoring},
  year={1987},
  volume={9},
  pages={255–258}
}
Knowledge of the pharmacokinetics of propylene glycol (PG) is scarce, though it is used in a number of preparations for intravenous use. Although systemic toxicity appears to be uncommon, PG has been reported to cause lactic acidosis and other adverse effects. We describe a rapid gas chromatographic assay method for PG and the plasma pharmacokinetics after intravenous administration to six patients on nine occasions. The pharmacokinetics were nonlinear, based on a saturable clearance. The… Expand
Pharmacokinetics of propylene glycol after rectal administration
TLDR
The pharmacokinetics after rectal administration are studied, followed by a consideration on local and systemic side-effects for a solution of paracetamol in a mixture of propylene glycol and water. Expand
Propylene glycol toxicity in children.
TLDR
L Laboratory monitoring of PG levels, osmolarity, lactate, pyruvate, bicarbonate, creatinine, and anion gap can assist practitioners in making the diagnosis of PG toxicity. Expand
A Prospective Evaluation of Propylene Glycol Clearance and Accumulation During Continuous-Infusion Lorazepam in Critically Ill Patients
TLDR
Fifty critically ill patients receiving continuous-infusion lorazepam for a minimum of 36 hours were prospectively evaluated to determine the extent of propylene glycol accumulation over time, characterize propylene Glycol clearance in the presence of critical illness, and develop a pharmacokinetic model that would predict clearance based on patient-specific clinical, laboratory, and demographic factors. Expand
Clinical pharmacology of propylene glycol in neonates
TLDR
The data on PG disposition and tolerance suggest that there is a lower limit of safe short term exposure to PG in neonates and that a safer level of exposure should finally be based on clearance estimates and level of tolerated exposure. Expand
Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy
TLDR
Hemodialysis may be a useful component of therapy for critically ill patients exhibiting propylene glycol toxicity in the context of multiple organ dysfunction. Expand
Low but Inducible Contribution of Renal Elimination to Clearance of Propylene Glycol in Preterm and Term Neonates
TLDR
Renal elimination of PG in (pre)term neonates is low, particularly compared with the reported percentage of 45% in adults, but it may increase with time after the first dose of PG, and further research is needed. Expand
Developmental pharmacokinetics of propylene glycol in preterm and term neonates.
TLDR
A pharmacokinetic model was developed for PG co-administered with paracetamol or phenobarbital in neonates and shows that large variability in PG exposure may be expected in Neonates which is dependent on birth weight and age of the neonates. Expand
Prospective assessment of short-term propylene glycol tolerance in neonates
TLDR
Unintended PG administration (34 mg/kg/24 h) for a maximum of 48 h seems to be tolerated in (pre)term neonates and does not affect short-term postnatal adaptations. Expand
Assessing Propylene Glycol Toxicity in Alcohol Withdrawal Patients Receiving Intravenous Benzodiazepines: A One-Compartment Pharmacokinetic Model
TLDR
It does not appear that intermittent bolus administration of intravenous benzodiazepines for alcohol withdrawal influenced renal function or anion gap regardless of number of administered doses, amount of PG received, or the estimated PG concentration. Expand
Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis.
TLDR
A case of toxicity from the drug solvent propylene glycol resulting from prolonged, large-dose lorazepam infusion is reported, unusual in that toxicity developed during continuous veno-venous hemofiltration with dialysis. Expand
...
1
2
3
4
5
...